[1] HODGE C,BADGWELL B D.Palliation of malignant ascites[J].J Surg Oncol,2019,120(1):67-73.
[2] 白杰,郑琪,张彦兵,等. 腹腔药物灌注治疗恶性腹水研究进展[J].医学综述,2021,27(9):1740-1746.
[3] ITO K,TSUBAMOTO H,INOUE K.Effectiveness of intraperitoneal or intrapleural administration of triamcinolone acetonide for the control of malignant ascites and pleural effusion (Kansai Clinical Oncology Group-G1102 study).[J].J Cancer Res Ther,2017,13(3):446-450.
[4] 姚睿嫔,俞超芹,张丹英,等. 榄香烯乳单药腔内注射缓解难治性卵巢癌恶性胸腹水(附12例)[J].现代肿瘤医学,2017,25(14):2288-2290.
[5] 杨学宁,吴一龙.实体瘤治疗疗效评价标准—RECIST[J].循证医学,2004,4(2):85-90.
[6] ZHANG W,LIU K,YE B,et al. Clinical and biological effects of tumorassociated lymphocytes in the presence or absence of chemotherapy for malignant ascites in ovarian cancer patients[J].Oncol Lett,2017,14(3):3379-3386.
[7] 李晨曦,曾昭武,陈浩,等. 榄香烯治疗恶性腹水疗效与安全性Meta分析[J].新中医,2018,50(5):200-203.
[8] 林智才,陈黎静,张雅雅,等. 榄香烯注射液联合卡铂注射液腔内注射治疗恶性胸腹腔积液的临床观察[J].河北中医,2018,40(12):1825-1828.
[9] 王静,杨英,王莹,等. 榄香烯腹腔灌注联合热疗治疗恶性腹腔积液疗效分析[J].浙江临床医学,2021,23(9):1305-1306.
[10] 王帅,刘素艳,李艳艳,等. 榄香烯联合奈达铂治疗恶性胸腹水临床观察[J].中华肿瘤防治杂志,2018,25(18):1328-1331. |
2022, Vol. 39 
